Syros and Tyme Technologies Announce Stockholder Approval of Merger Sep 15, 2022 04:13PM
Syros Pharmaceuticals (SYRS) and Tyme Technologies (TYME) Shareholders Approve Merger Sep 15, 2022 04:02PM
Syros and Tyme Technologies Announce Stockholder Approval of Merger Sep 15, 2022 04:01PM
Syros Pharmaceuticals (SYRS) to Raise Approximately $190 Million Through Merger with TYME Technologies (TYME) and Concurrent Private Placement Jul 5, 2022 07:02AM
Syros to Raise Approximately $190 Million Through Merger with TYME Technologies and Concurrent Private Placement Jul 5, 2022 07:00AM


May 25, 2022 07:17AM Tyme Technologies (TYME) Reports FY22 Net Loss of $23M, Cash Position of $84M
May 25, 2022 07:15AM TYME Technologies, Inc. Reports Fourth Fiscal Quarter and Full Year 2022 Financial and Operating Results
Mar 25, 2022 08:06AM Tyme Technologies (TYME) Announces Board Changes
Mar 25, 2022 08:00AM TYME Technologies, Inc. Announces Changes to its Board of Directors
Mar 9, 2022 06:50AM TYME Technologies, Inc. Announces SM-88 Poster at the American Association for Cancer Research (AACR) Annual Meeting 2022
Mar 9, 2022 06:50AM TYME Technologies, Inc. Announces SM-88 Poster at the American Association for Cancer Research (AACR) Annual Meeting 2022
Feb 11, 2022 06:52AM Tyme Technologies (TYME) Reports Q3 EPS of ($0.03), Provides Business Update
Feb 11, 2022 06:50AM TYME Technologies, Inc. Provides Business Update and Announces Third Fiscal Quarter 2022 Financial and Operating Results
Jan 27, 2022 04:30PM TYME Technologies, Inc. to Host Conference Call and Webcast on Friday, February 11, at 8:30 AM ET
Jan 26, 2022 06:51AM Tyme Technologies (TYME) Announces Discontinuation of SM-88 and MPS Tria
Jan 26, 2022 06:50AM TYME Technologies, Inc. Provides Update on Precision Promise Trial in Metastatic Pancreatic Cancer
Jan 3, 2022 04:05PM TYME Technologies, Inc. to Present at H.C. Wainwright Bioconnect Virtual Conference
Dec 14, 2021 06:50AM Tyme Technologies (TYME) Announces Additional Encouraging Preclinical Data on the Effect of TYME-19 in SARS CoV-2 Infections
Dec 14, 2021 06:50AM TYME Technologies, Inc. Announces Additional Encouraging Preclinical Data on the Effect of TYME-19 in SARS CoV-2 Infections
Dec 9, 2021 06:50AM TYME Technologies, Inc. Announces Oral SM-88 Poster Accepted for Presentation at the 2022 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium
Nov 8, 2021 06:51AM Tyme Technologies (TYME) Issues Business Update; Reports Q2 Earnings
Nov 8, 2021 06:50AM TYME Technologies, Inc. Provides Business Update and Announces Second Fiscal Quarter 2022 Financial and Operating Results
Nov 2, 2021 05:30PM TYME Technologies, Inc. to Present at Jefferies London Healthcare Conference
Oct 27, 2021 04:30PM TYME Technologies, Inc. to Host Conference Call and Webcast on Monday, November 8th at 8:30 AM ET
Sep 27, 2021 06:50AM TYME Announces First Patient Dosed in Phase II OASIS Trial Evaluating the Potential Benefits of Oral SM-88 for Patients with Metastatic HR+/HER2- Breast Cancer After Treatment with a CDK4/6 Inhibitor
Sep 2, 2021 06:50AM TYME Technologies, Inc. to Present at Upcoming Virtual Healthcare Industry Conferences
Aug 10, 2021 06:45AM TYME Technologies, Inc. Provides Business Update and Announces Fiscal First Quarter 2022 Financial and Operating Results
Aug 2, 2021 04:05PM TYME Technologies, Inc. to Host Conference Call and Webcast on Tuesday, August 10th at 8:30 AM ET
Jul 26, 2021 08:25AM Tyme Technologies (TYME) Granted U.S. Patent Claims Covering Use of Tyrosine-Based Drug Delivery Method to Treat Cancer
Jul 26, 2021 08:05AM Tyme Granted U.S. Patent Claims Covering Use of Tyrosine-Based Drug Delivery Method to Treat Cancer
Jun 10, 2021 04:19PM Tyme Technologies (TYME) Completes Strategic Review, Announces OASIS Breast Trial With Georgetown University, and Reports FY21 Financial Results
Jun 10, 2021 04:17PM Tyme Technologies, Inc. Completes Strategic Review, Announces OASIS Breast Trial With Georgetown University, and Reports Fiscal Year 2021 Financial Results
May 26, 2021 08:05AM TYME Technologies, Inc. to Host Conference Call and Live Video Webcast on Thursday, June 10th at 5:00 PM ET
May 13, 2021 09:05AM Tyme Technologies (TYME) Announces Frank L. Porfido as CFO
May 13, 2021 09:05AM TYME Appoints Frank L. Porfido as Chief Financial Officer
May 10, 2021 09:05AM TYME Announces Abstract Selected for Publication at the 2021 American Society of Clinical Oncology Annual Meeting
Apr 1, 2021 08:00AM TYME Announces Appointment of Dr. Jan M Van Tornout as Acting Chief Medical Officer
Feb 3, 2021 08:07AM Tyme Technologies (TYME) Granted U.S. Patent Claims Covering Use of TYME-19 to Treat COVID-19 Infections
Feb 3, 2021 08:00AM TYME Granted U.S. Patent Claims Covering Use of TYME-19 to Treat COVID-19 Infections
Dec 9, 2020 08:00AM TYME Announces SM-88 Abstract Selected for Presentation at the American Society of Clinical Oncology 2021 Gastrointestinal Cancers Symposium
Jun 23, 2020 08:04AM Tyme Inc. (TYME) Highlights New Preclinical Data Showing Anti-Cancer Effect of Cancer Metabolism-Based Pipeline Candidate, TYME-18
Jun 23, 2020 08:00AM TYME-18 Demonstrates Anti-Cancer Effect in New Preclinical Data Presented at AACR 2020
Jun 22, 2020 08:05AM Tyme Inc. (TYME) Highlights New Preclinical Data Supporting SM-88 Mechanism of Action
Jun 22, 2020 08:00AM TYME Presents New Preclinical Data Supporting SM-88 Mechanism of Action at AACR 2020
Oct 1, 2019 08:30AM LineaRx’s iCTC Platform for Isolation of Circulating Tumor Cells Shows Superior Correlation over PSA as a Biomarker in Prostate Cancer Trial
Aug 7, 2017 11:31AM Tyme Technologies Inc. (Nasdaq: TYME) to Ring The Nasdaq Stock Market Opening Bell